Back to Journals » Core Evidence » Volume 14

Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy

Total article views   Abstract views HTML views PDF downloads Totals
6,241 Dovepress* 2,042 499+ 927 2,541
PubMed Central* 0 3,700 487 3,700
Totals 2,042 4,199 1,414 6,241
*Since 26 April 2019
+Since July 2016

View citations on PubMed Central and Google Scholar